Roche Enters Definitive Merger Agreement To Acquire AI-Driven Digital Pathology Company PathAI For $750M Upfront And Up To $300M In Additional Milestone Payments
PathAI's best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiency
Combining Roche's strong position in companion diagnostics and PathAI's advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers and create novel diagnostic tools
These integrated capabilities will accelerate the shift from broad intervention toward personalised healthcare for patients
Login to comment